Log In
Print this Print this

Polyclonal Antibody Stimulator (PAS)

  Manage Alerts
Collapse Summary General Information
Company Cancer Advances Inc.
DescriptionFusion peptide immunomodulator
Molecular Target
Mechanism of ActionImmune modulation
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today